Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7016
-0.0184 (-2.56%)
At close: Apr 16, 2026, 4:00 PM EDT
0.7016
0.00 (0.00%)
After-hours: Apr 16, 2026, 4:00 PM EDT
Envoy Medical Employees
As of December 31, 2025, Envoy Medical had 47 total employees, including 43 full-time and 4 part-time employees. The number of employees increased by 5 or 11.90% compared to the previous year.
Employees
47
Change (1Y)
5
Growth (1Y)
11.90%
Revenue / Employee
$5,128
Profits / Employee
-$609,830
Market Cap
53.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 47 | 5 | 11.90% | 43 | 4 |
| Dec 31, 2024 | 42 | 8 | 23.53% | 42 | 0 |
| Dec 31, 2023 | 34 | -1 | -2.86% | 34 | 0 |
| Jun 30, 2023 | 35 | - | - | 35 | 0 |
| Mar 31, 2023 | 35 | - | - | 35 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Accuray | 990 |
| Nortech Systems | 713 |
| Pulmonx | 296 |
| Baird Medical Investment Holdings | 143 |
| InspireMD | 127 |
| electroCore | 83 |
| Spectral AI | 65 |
| PAVmed | 41 |
COCH News
- 8 hours ago - Envoy Medical Appoints Chas McKhann to Board of Directors - Newsfile Corp
- 15 days ago - Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant - Newsfile Corp
- 24 days ago - Envoy Medical Reports Full Year 2025 Financial Results - Newsfile Corp
- 5 weeks ago - Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant - Newsfile Corp
- 7 weeks ago - Envoy Medical Regains Compliance with Nasdaq Listing Requirement - Newsfile Corp
- 7 weeks ago - Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - Newsfile Corp
- 2 months ago - Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - Newsfile Corp
- 2 months ago - Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Newsfile Corp